A detailed history of Hrt Financial LP transactions in Alkermes Plc. stock. As of the latest transaction made, Hrt Financial LP holds 314,443 shares of ALKS stock, worth $8.86 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
314,443
Holding current value
$8.86 Million
% of portfolio
0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.01 - $28.55 $7.24 Million - $8.98 Million
314,443 New
314,443 $8.8 Million
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $1.64 Million - $1.92 Million
60,196 New
60,196 $1.69 Million
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $750,314 - $860,297
29,645 New
29,645 $835,000
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $474,298 - $687,085
21,559 Added 82.96%
47,546 $1.06 Million
Q2 2022

Aug 12, 2022

SELL
$26.4 - $30.54 $227,092 - $262,705
-8,602 Reduced 24.87%
25,987 $774,000
Q1 2022

May 16, 2022

BUY
$23.07 - $27.99 $797,968 - $968,146
34,589 New
34,589 $910,000
Q2 2021

Aug 16, 2021

SELL
$18.78 - $25.15 $2.47 Million - $3.31 Million
-131,418 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$18.21 - $23.2 $1.53 Million - $1.95 Million
83,935 Added 176.77%
131,418 $2.45 Million
Q4 2020

Feb 16, 2021

BUY
$15.39 - $22.1 $490,371 - $704,172
31,863 Added 203.99%
47,483 $947,000
Q3 2020

Nov 13, 2020

SELL
$16.16 - $20.66 $97,428 - $124,559
-6,029 Reduced 27.85%
15,620 $258,000
Q2 2020

Aug 14, 2020

BUY
$13.31 - $19.41 $288,148 - $420,207
21,649 New
21,649 $420,000
Q1 2020

May 15, 2020

SELL
$13.06 - $21.24 $2.45 Million - $3.98 Million
-187,364 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$17.29 - $21.74 $2.64 Million - $3.32 Million
152,797 Added 442.03%
187,364 $3.82 Million
Q3 2019

Nov 14, 2019

BUY
$19.51 - $24.28 $674,402 - $839,286
34,567 New
34,567 $674,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.63B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.